Table 3.
Cytotoxicity and Antimicrobial Activity of Compounds Isolated from Mitrephora glabra
| IC50 values (μg/mL)a | minimal inhibitory concentration (μg/mL)b | |||||||
|---|---|---|---|---|---|---|---|---|
| compound | KB | MCF-7 | H460 | SF-268 | M. luteus | M. smegmatis | S. cerevisiae | A. niger |
| 1 | 8.0 | 15.7 | 23.3 | 30.9 | 125 | 63 | 63 | 63 |
| 2 | 7.0 | Inactive | Inactive | Inactive | 88 | 88 | 88 | 88 |
| 3 | Inactivec | Inactive | Inactive | Inactive | 63 | 31 | 31 | 63 |
| 4 | Inactive | Inactive | Inactive | Inactive | 19 | 75 | 75 | 75 |
| positive controlsd | 0.005 (camptothecin) | 0.025 (camptothecin) | 0.002 (camptothecin) | 0.021 (camptothecin) | 0.1 (ampicillin) | 0.2 (kanamycin) | 25 (amphotericin B) | 25 (amphotericin B) |
KB: human oral epidermoid carcinoma; MCF-7: human mammary adenocarcinoma; H460: human non-small cell (large cell) lung carcinoma; SF-268: human astrocytoma. IC50 values are determined as the concentration required to reduce cellular staining with sulforhodamine B by 50% relative to untreated controls following 72 h of continuous exposure.17
Minimal inhibitory concentration is the lowest concentration of compound completely inhibiting growth (as turbidity) expressed in μg/mL.17
Inactive = IC50value > 30 μg/mL.
Average values.